Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study

References

• World Health Organization. Cardiovascular diseases (CVDs). Geneva: World Health Organization; 2017. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed August 27, 2019.
   Google Scholar
• Gheorghe A, Griffith U, Murphy A, et al. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018;18(1):975. doi:10.1186/s12889-018-5806-x
   PubMed Web of Science ®Google Scholar
• NCD Alliance. The global epidemic: non-communicable diseases (NCDs) are the world’s #1 killer, bringing hardship to rich and poor nations alike; 2015. Available from: https://ncdalliance.org/the-global-epidemic. Accessed August 28, 2019.
   Google Scholar
• Ruan Y, Guo Y, Zheng Y, et al. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE wave 1. BMC Public Health. 2018;18(1):778. doi:10.1186/s12889-018-5653-9
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): Case-Control Study. Lancet. 2004;364(9438):937–952. doi:10.1016/S0140-6736(04)17018-9
   PubMed Web of Science ®Google Scholar
• Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013;55(6):590–600. doi:10.1016/j.pcad.2013.02.001
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfel JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986
   PubMed Web of Science ®Google Scholar
• Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24(2):71–77. doi:10.2337/diaclin.24.2.71
   Google Scholar
• Perel P, Avezum A, Huffman M, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease. Glob Heart. 2015;10(2):99–110. doi:10.1016/j.gheart.2015.04.003
   Google Scholar
• Mechael P, Batavia H, Kaonga N, et al. Barriers and Gaps Affecting Mhealth in Low and Middle Income Countries. Washington, DC: mHealth Alliance; 2010. Policy white paper.
   Google Scholar
• World Health Organization. Risk of premature death from target NCDs data by country. Geneva: World Health Organization; 2018. Available from: http://apps.who.int/gho/data/view.main.2485. Accessed November 11, 2019.
   Google Scholar
• Lamptey P, Laar A, Adler AJ, et al. Evaluation of a community-based hypertension improvement program (ComHIP) in Ghana: data from a baseline survey. BMC Public Health. 2017;17(1):368. doi:10.1186/s12889-017-4260-5
   Web of Science ®Google Scholar
• Lloyd-Sherlock P, Beard J, Minicuci N, et al. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43(1):116–128. doi:10.1093/ije/dyt215
   PubMed Web of Science ®Google Scholar
• Prabhakaran D, Jeemon P, Roy A. Cardiovascular disease in India. Circulation. 2016;133(16):1605–1620. doi:10.1161/CIRCULATIONAHA.114.008729
   PubMed Web of Science ®Google Scholar
• Subramanian SV, Corsi DJ, Subramanyam MA, et al. Jumping the gun: the problematic discourse on socioeconomic status and cardiovascular health in India. Int J Epidemiol. 2013;42(5):1410–1426. doi:10.1093/ije/dyt017
   PubMed Web of Science ®Google Scholar
• Yusuf S. Two decades of progress in preventing vascular disease. Lancet. 2002;360(9326):2–3. doi:10.1016/S0140-6736(02)09358-3
   PubMed Web of Science ®Google Scholar
• Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378(9798):1231–1243. doi:10.1016/S0140-6736(11)61215-4
   PubMed Web of Science ®Google Scholar
• Jackson C, Eliasson L, Barber N, Weinman J. Applying COM-B to medication adherence: a suggested framework for research and intervention. Eur J Health Psychol. 2014;16:7–17.
   Google Scholar
• Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(42). doi:10.1186/1748-5908-6-42
   Web of Science ®Google Scholar
• Lee SK, Kang BY, Kim HG, et al. Predictors of medication adherence in elderly patients with chronic diseases using support vector machine models. Healthc Inform Res. 2013;19(1):33–41. doi:10.4258/hir.2013.19.1.33
   Google Scholar
• Saqlain M, Riaz A, Malik MN, et al. Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients in Islamabad, Pakistan. Medicina (Kaunas). 2019;55(5):163. doi:10.3390/medicina55050163
   Web of Science ®Google Scholar
• Legido-Quigley H, Naheed A, Silva HA, et al. Patients’ experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: a Qualitative Study. PLoS One. 2019;14(1):e0211100. doi:10.1371/journal.pone.0211100
   Web of Science ®Google Scholar
• Khatib R, Schwalm J-D, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238. doi:10.1371/journal.pone.0084238
   PubMed Web of Science ®Google Scholar
• Maimaris W, Paty J, Perel P, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013;10(7):e1001490. doi:10.1371/journal.pmed.1001490
   Web of Science ®Google Scholar
• Balasubramanian A, Nair S, Rakesh PS, Leelamoni K. Adherence to treatment among hypertensives of rural Kerala, India. Fam Med Prim Care Rev. 2018;7(1):64–69. doi:10.4103/jfmpc.jfmpc_423_16
   Google Scholar
• Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a Retrospective Cohort Study. Diabet Med. 2002;19(4):279–284. doi:10.1046/j.1464-5491.2002.00689.x
   PubMed Web of Science ®Google Scholar
• Qureshi NN, Hatcher J, Chaturvedi N, et al. Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial. BMJ. 2007;335(7628):1030. doi:10.1136/bmj.39360.617986.AE
   Web of Science ®Google Scholar
• Pradhan Mantri Jan Arogya Yojana. About Pradhan Mantri Jan Arogya Yojana (PM-JAY). New Delhi: National Health Authority, Government of India; 2018. Available from: https://pmjay.gov.in/about/pmjay. Accessed October 5, 2020.
   Google Scholar
• World Health Organisation. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003. Available from https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1. Accessed November 25, 2019.
   Google Scholar